Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and Patient Selection

Peura, Jennifer L.; Colvin-Adams, Monica; Francis, Gary S.; Grady, Kathleen L.; Hoffman, Timothy M.; Jessup, Mariell; John, Ranjit; Kiernan, Michael S.; Mitchell, Judith E.; O’Connell, John B.; Pagani, Francis D.; Petty, Michael; Ravichandran, Pasala; Rogers, Joseph G.; Semigran, Marc J.; O’Toole, John M.

doi:10.1161/cir.0b013e3182769a54

Cited by 280 publications

(155 citation statements)

References 135 publications

Supporting

Mentioning

140

Contrasting

Unclassified

Order By: Relevance

“…On the other hand, some acceptable states, appropriate patient selection may be important. In advanced heart failure patients undergoing cardiac transplantation and mechanical circulatory support, the Interagency Registry for Mechanically Circulatory Support (INTERMACS) profiles have been proposed to estimate the potential for severe heart failure [22] [23] [24]. These profiles could be helpful for patient selection for left ventricular plasty (LVP) in the treatment of patients with severe DCM.…”

Section: Discussionmentioning

confidence: 99%

Modified Batista Procedure for Idiopathic Dilated Cardiomyopathy: Report of a Case

Morimoto¹,

Kuroda²,

Ono³

et al. 2017

WJCS

View full text Add to dashboard Cite

The surgical indications for dilated cardiomyopathy (DCM) remain controversial, not including cardiac transplantation and mechanical circulatory support. We describe a case of idiopathic DCM that underwent successful surgical treatment using a modified left ventriculectomy, modification of the Batista procedure. The patient was a 63-year-old man who suffered from heart failure, New York Heart Association (NYHA) Class IV. Heart failure was derived from idiopathic DCM with a severely compromised left ventricular function complicated by left ventricular thrombosis. He underwent successful surgical treatment, specifically partial left ventriculectomy combined with the papillary muscle approximation, and the postoperative course was uneventful. He has been well with NYHA Class I for 3 years after the operation without heart failure.

show abstract

Section: Discussionmentioning

confidence: 99%

Modified Batista Procedure for Idiopathic Dilated Cardiomyopathy: Report of a Case

Morimoto¹,

Kuroda²,

Ono³

et al. 2017

WJCS

View full text Add to dashboard Cite

show abstract

“…Pueden ser agrupados según su localización como paracorpóreos o intracorpóreos; según el tipo de flujo, en pulsátil o continuo; según se asista uno o los dos ventrículos en uni o biventriculares y según el tiempo de la asistencia en corta, mediana o larga duración 8,9 . Estos últimos pueden ser utilizados por meses o incluso años.…”

Section: Discussionunclassified

“…En este complejo escenario, los dispositivos de asistencia ventricular (VADs) aparecen como una opción válida, para mejorar la condición de un paciente previo al TxC (puente al trasplante) o como una terapia definitiva para aquéllos pacientes con contraindicaciones para TxC (terapia de destinación) 8,9 .…”

unclassified

Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II

Bunster¹,

Villavicencio

Lim³

et al. 2014

Rev. méd. Chile

View full text Add to dashboard Cite

show abstract

“…Use of LVADs has grown steadily over the past decade since their initial approval for use as a bridge-totransplantation (BTT). Second and third generation LVADs have achieved improved durability through the use of wear free components, allowing for the upgrading of LVAD use to a destination therapy (DT) strategy in patients who are ineligible for HTx (8). LVADs provide patients with significant clinical improvement and prolong survival but are not free of complications (9).…”

Section: Introductionmentioning

confidence: 99%

Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis

Theochari¹,

Michalopoulos²,

Oikonomou³

et al. 2018

Ann. Cardiothorac. Surg.

View full text Add to dashboard Cite

Background: The optimal treatment for advanced heart failure (HF) patients with regards to mortality remains unknown. Heart transplantation (HTx) and left ventricular assist devices (LVAD) used either as a bridge to transplant (BTT) or destination therapy (DT) have been compared in a number of studies, without definite conclusions with regards to mortality benefit. We sought to systematically review the pertinent literature and perform a meta-analysis of all the available studies presenting head-to-head comparisons between HTx and LVAD BTT or LVAD DT for late (>6 months) all-cause mortality.Methods: We performed a systematic search of Medline and Cochrane Central databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We conducted a meta-analysis of late mortality comparing HTx vs. BTT LVAD and HTx vs. DT LVAD using a random effects model.Results: Eight studies were included in our meta-analysis, reporting data on 7,957 patients in total.Although the available studies are of high quality [8 stars in Newcastle-Ottawa Scale (NOS) on average], there is paucity of mortality data. Specifically, seven studies compared HTx with BTT and five studies compared HTx with DT for 1-year mortality. Our pooled estimates showed that there was no difference in late mortality among these strategies. Conclusions:Our meta-analysis highlights the small number and the heterogeneity of available studies referring to the optimal invasive management of advanced HF, and shows that there are no differences between HTx and LVAD for these patients with regards to late mortality.

show abstract

Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and Patient Selection

Cited by 280 publications

References 135 publications

Modified Batista Procedure for Idiopathic Dilated Cardiomyopathy: Report of a Case

Modified Batista Procedure for Idiopathic Dilated Cardiomyopathy: Report of a Case

Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II

Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis

Contact Info

Product

Resources

About